Clinical Podcast: Treating the Thoracolumbar Junction for those with Hip Pain | Jeff Meadows • Posts by EIM | Evidence In Motion Skip To Content

Clinical Podcast: Treating the Thoracolumbar Junction for those with Hip Pain | Jeff Meadows

September 18, 2019 • Orthopaedics • John Childs

On today’s episode, Jeff Meadows, PT, DPT, OCS, COMT, FAAOMPT, joins Dr. John Childs and Dr. Mark Shepherd to discuss Jeff’s new research on the thoracolumbar junction, Short-term Response to Treatment Targeting the Thoracolumbar Junction in Patients With Hip Pain: A Case Series.

Listen in as they discuss takeaways from the article, how the research can affect clinical reasoning, and how important asterisks signs are in regional treatment.

Links:

Research atricle: Short-term Response to Treatment Targeting the Thoracolumbar Junction in Patients With Hip Pain: A Case Series
Jeff Meadows
@EIMTeam
@ShepDPT
@childsjd

John Childs

Dr. Childs is a founder and CEO of Evidence In Motion and partner in Confluent Health, which includes EIM; a network of 70+ physical therapy clinics in Indiana, Kentucky, North Carolina, Oklahoma, and Texas; and Fit for Work, which provides employers consultative services to decrease injuries and workers’ compensation costs. A graduate from the U.S....

––– Related Items


––– Comments

Sarah From Los Angeles

Commented • September 23, 2019

As someone who works with plumbers and can see how the body can wear down after a while due to the constant workload this did give me some factors to ponder upon

Matthew Warburton

Commented • September 20, 2019

This was really quite enjoyable to listen to. As a practicing MD from thre UK I actually learnt something new! I practice with Joint Pain at my online Clinic. Really Wonderful. Thank you Dr. John Childs, Dr. Mark Shepherd and JeffMeadows. I will tune in again. Dr. Matthew Warburton


––– Post a Comment

— All comments subject to approval

Your email address will not be published. Required fields are marked *

Sign up for news

Join the EIM Mailing List to receive next level updates on research, news, and educational offerings.